计划和非计划的肉瘤切除:局部复发,转移和死亡率的比较分析
Kim N Nydegger1,2, Timothy T A F Obergfell1,2, Philip Heesen3
1Faculty of Health Sciences and Medicine, University of Lucerne, Frohburgstrasse 3, 6002 Luzern, Switzerland.
Cancers
|October 16, 2024
概括
瘤患者的计划切除 (PEs) 产生更好的初始手术结果,但显示出更高的转移和死亡率. 无计划切除 (UE) 有更多的局部复发,但没有显著影响生存,强调了早期检测的必要性.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 癌症研究 癌症研究
背景情况:
- 瘤是源于介质细胞组织的复杂恶性瘤,具有重大诊断和治疗挑战.
- 本研究研究了计划切除 (PEs) 与非计划切除 (UE) 在肉瘤管理中的比较结果.
研究的目的:
- 为了比较软组织和骨肉瘤患者的计划切除 (PE) 和计划外切除 (UE) 的临床结果.
- 确定影响非计划切除的因素及其对患者生存和复发的影响.
主要方法:
- 来自瑞士肉瘤网络 (SSN) 的数据分析,包括429名软组织和骨肉瘤患者.
- 利用后勤和考克斯回归模型来评估UE的可能性及其对局部无复发生存率,无转移生存率 (MFS) 和整体生存率 (OS) 的影响.
主要成果:
- 计划切除 (PEs) 与更大和更高等级的瘤有关,但实现了更高的切除率 (R0).
- 尽管边际较好,但PE与UE相比,PE的转移率和癌症特异性死亡率显著更高.
- 非计划切除 (UE) 与较高的局部复发率有关,但没有显著影响MFS或OS.
结论:
- 虽然PE提供了更好的即时手术结果,但由于晚期瘤阶段,它们与转移和死亡率的增加有关.
- 尽管UE的局部复发率较高,但并没有显著影响长期生存结果 (MFS和OS).
- 强调早期检测,全面诊断和及时转诊到专门的肉瘤中心的关键需要,以最大限度地减少UEs和减少转移风险.
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:24Kaplan-Meier Approach
103
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
103